Publication | Open Access

Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial

PsychopathologyPsychiatryMood SymptomPsychotropic MedicationDepression Symptom SeverityDepressionNeuropharmacologySocial SciencesNeurosciencePsychiatric DisorderMental HealthPsilocybin Versus EscitalopramPhase 2MedicinePsychology